These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 24384432
1. Retrospective study of mycophenolate mofetil treatment in IgA nephropathy with proliferative pathological phenotype. Liang Y, Zhang J, Liu D, Quan S, Xing G, Liu Z. Chin Med J (Engl); 2014; 127(1):102-8. PubMed ID: 24384432 [Abstract] [Full Text] [Related]
2. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial. Hou JH, Le WB, Chen N, Wang WM, Liu ZS, Liu D, Chen JH, Tian J, Fu P, Hu ZX, Zeng CH, Liang SS, Zhou ML, Zhang HT, Liu ZH. Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945 [Abstract] [Full Text] [Related]
3. Delayed severe pneumonia in mycophenolate mofetil-treated patients with IgA nephropathy. Lv J, Zhang H, Cui Z, Su T, Zhang Y, Wang H. Nephrol Dial Transplant; 2008 Sep; 23(9):2868-72. PubMed ID: 18463325 [Abstract] [Full Text] [Related]
6. Treatment of severe IgA nephropathy: mycophenolate mofetil/prednisone compared to cyclophosphamide/prednisone. Liu X, Dewei D, Sun S, Xu G, Liu H, He L, Zhang P. Int J Clin Pharmacol Ther; 2014 Feb; 52(2):95-102. PubMed ID: 24161158 [Abstract] [Full Text] [Related]
7. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children]. Yi ZW, Wu XC, Xu H, Zhou LJ, Wu YB, Feng SP, Zhou JH, Yang Q, Zhu GH, Liu AM, Wei MJ, Yu L, Zeng ZF. Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):575-8. PubMed ID: 18947472 [Abstract] [Full Text] [Related]
8. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Hu W, Liu C, Xie H, Chen H, Liu Z, Li L. Nephrol Dial Transplant; 2008 Apr; 23(4):1307-12. PubMed ID: 18065810 [Abstract] [Full Text] [Related]
9. Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review. Chen Y, Li Y, Yang S, Li Y, Liang M. BMC Nephrol; 2014 Dec 05; 15():193. PubMed ID: 25475967 [Abstract] [Full Text] [Related]
19. [Mycophenolate mofetil in high risk IgA glomerulonephritis]. Frutos MA, López V, Alférez MJ, Aranda P. Nefrologia; 2005 Jun 01; 25(4):387-92. PubMed ID: 16231504 [Abstract] [Full Text] [Related]
20. Mycophenolate mofetil in the treatment of IgA nephropathy: a systematic review. Tan CH, Loh PT, Yang WS, Chan CM. Singapore Med J; 2008 Oct 01; 49(10):780-5. PubMed ID: 18946610 [Abstract] [Full Text] [Related] Page: [Next] [New Search]